.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 4,920,143

« Back to Dashboard

Claims for Patent: 4,920,143

Title: Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
Abstract:A group of hydro-monobenzoporphyrins "green porphyrins" (Gp) having absorption maxima in the range of 670-780 nanometers is useful in treating disorders or conditions which are subject to hematoporphyrin derivative (HPD) treatment in the presence of light, or in treating virus, cells and tissues generally to destroy unwanted targets. The use of the Gp of the invention permits the irradiation to use wavelengths other than those absorbed by blood. The Gp of the invention may also be conjugated to ligands specific for receptor or to specific immunoglobulins or fragments thereof to target specific tissues or cells for the radiation treatment. Use of these materials permits lower levels of drug to be used, thus preventing side reactions which might destroy normal tissues.
Inventor(s): Levy; Julia G. (Vancouver, CA), Dolphin; David (Vancouver, CA), Chow; Jack K. (Burnaby, CA), Sternberg; Ethan (Vancouver, CA)
Assignee: University of British Columbia (Vancouver, CA)
Application Number:07/221,161
Patent Claims: 1. A compound of the formula ##STR7## wherein each R.sup.1 and R.sup.2 is independently selected from the group consisting of carbalkoxy (1-6C), alkyl (1-6C) sulfonyl, aryl sulfonyl, and aryl, and

each R.sup.3 is independently CH.sub.2 CH.sub.2 COOR.sup.3' where R.sup.3' is H or alkyl (1-6C); and

R.sup.4 is CHCH.sub.2, CH.sub.2 OR.sup.4', CH(OR.sup.4')CH.sub.3, CH(OR.sup.4')CH.sub.2 OR.sup.4', --CH(SR.sup.4')CH.sub.3, --CH(NR.sup.4'.sub.2)CH.sub.3, --CH(CN)CH.sub.3, --CH(COOR.sup.4')CH.sub.3, --CH(OOCR.sup.4', )CH.sub.3, --CH(halo)CH.sub.3, and --CH(halo)CH.sub.2 (halo), wherein R.sup.4' is H, alkyl (1-6C), with the proviso that if R.sup.4 is CHCH.sub.2, both R.sup.3', cannot be alkyl.

2. The compound of claim 1 wherein R.sup.1 and R.sup.2 are carbalkoxy.

3. The compound of claim 2 wherein R.sup.1 and R.sup.2 are carbomethoxy or carboethoxy.

4. The compound of claim 2 which is of formulae mulae 3 or 4 of FIG. 1.

5. The compound of claim 2 wherein R.sup.4 is selected from --CHCH.sub.2, --CH(OH)CH.sub.3 and --CH(halo)CH.sub.3.

6. The compound of claim 2 which is selected from compounds of the formula ##STR8## wherein R is alkyl (1-6C).

7. The compound of claim 5 which is of the formula

8. A pharmaceutical composition which is useful in targeting specific biological material which composition comprises an effective amount of the compound of claim 1 in admixture with at least one pharmaceutically acceptable excipient.

9. A pharmaceutical composition which is useful in targeting specific biological material which composition comprises an effective amount of the compound of claim 5 in admixture with at least one pharmaceutically acceptable excipient.

10. A pharmaceutical composition which is useful in targeting specific biological material which composition comprises an effective amount of the compound of claim 6 in admixture with at least one pharmaceutically acceptable excipient.

11. A pharmaceutical composition which is useful in targeting specific biological material which composition comprises an effective amount of the compound of claim 7 in admixture with at least one pharmaceutically acceptable excipient.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc